Geoffrey Meyerson is the Co-founder and CEO of Banyan BioInnovations Capital Fund I. Organization, location and related investors we track.
Geoffrey Meyerson is the Co-founder and CEO of Banyan BioInnovations Capital Fund I, a Boston-based venture capital firm he launched with Co-founder and President Barbara White. The firm focuses on Series A investments in clinical-stage drug assets, aiming to develop independent companies from promising treatments primarily within the life sciences sector. Banyan BioInnovations raised over $100 million in initial commitments for its debut fund, though specific check sizes and lead-versus-follow behavior are not publicly detailed. Notable portfolio activity includes a strategic partnership with global contract research organization ICON to support asset development, but the search results do not list additional named portfolio companies. Meyerson emphasizes building deep, personal relationships with deal counterparts rather than transactional interactions, advising investors to meet directly with company chairmen to understand their motivations. He has no publicly available distinctive point of view or published writing beyond these interview comments on deal-making strategy in biopharma.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Boston.
Investors like Geoffrey Meyerson · Full investor directory · Investor access · Company funding database